atenolol has been researched along with Wolff-Parkinson-White Syndrome in 3 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Wolff-Parkinson-White Syndrome: A form of ventricular pre-excitation characterized by a short PR interval and a long QRS interval with a delta wave. In this syndrome, atrial impulses are abnormally conducted to the HEART VENTRICLES via an ACCESSORY CONDUCTING PATHWAY that is located between the wall of the right or left atria and the ventricles, also known as a BUNDLE OF KENT. The inherited form can be caused by mutation of PRKAG2 gene encoding a gamma-2 regulatory subunit of AMP-activated protein kinase.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Adenosine is effective in rapidly terminating maternal narrow complex tachyarrhythmias before and during delivery in women with Wolff-Parkinson-White syndrome." | 7.68 | Termination of supraventricular tachycardia with intravenous adenosine in a pregnant woman with Wolff-Parkinson-White syndrome. ( Afridi, I; Moise, KJ; Rokey, R, 1992) |
| "5) diagnostic His bundle studies incorporating programmed atrial and ventricular pacing for the induction of tachycardias was performed before and after betablockade with the cardioselective betablocking agent atenolol, in a dose of 5 mg given iv." | 7.66 | Antiarrhythmic effects of acute betablockade with atenolol on supraventricular tachycardias at rest and during exercise. ( Behrenbeck, DW; Braun, V; Gil-Sanchez, D; Hilger, HH; Hombach, V; Höpp, HW; Tauchert, M, 1981) |
| "Adenosine is effective in rapidly terminating maternal narrow complex tachyarrhythmias before and during delivery in women with Wolff-Parkinson-White syndrome." | 3.68 | Termination of supraventricular tachycardia with intravenous adenosine in a pregnant woman with Wolff-Parkinson-White syndrome. ( Afridi, I; Moise, KJ; Rokey, R, 1992) |
| "5) diagnostic His bundle studies incorporating programmed atrial and ventricular pacing for the induction of tachycardias was performed before and after betablockade with the cardioselective betablocking agent atenolol, in a dose of 5 mg given iv." | 3.66 | Antiarrhythmic effects of acute betablockade with atenolol on supraventricular tachycardias at rest and during exercise. ( Behrenbeck, DW; Braun, V; Gil-Sanchez, D; Hilger, HH; Hombach, V; Höpp, HW; Tauchert, M, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morley-Smith, EJ | 1 |
| Gagg, J | 1 |
| Appelboam, A | 1 |
| Hombach, V | 1 |
| Braun, V | 1 |
| Höpp, HW | 1 |
| Gil-Sanchez, D | 1 |
| Behrenbeck, DW | 1 |
| Tauchert, M | 1 |
| Hilger, HH | 1 |
| Afridi, I | 1 |
| Moise, KJ | 1 |
| Rokey, R | 1 |
3 other studies available for atenolol and Wolff-Parkinson-White Syndrome
| Article | Year |
|---|---|
Cardioversion of a supraventricular tachycardia (SVT) in a 7-year-old using a postural modification of the Valsalva manoeuvre.
Topics: Adenosine; Administration, Intravenous; Aftercare; Anti-Arrhythmia Agents; Atenolol; Child; Electric | 2017 |
Antiarrhythmic effects of acute betablockade with atenolol on supraventricular tachycardias at rest and during exercise.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atenolol; Cardiac Pacing, Artificial; Electric Stimulation; Ele | 1981 |
Termination of supraventricular tachycardia with intravenous adenosine in a pregnant woman with Wolff-Parkinson-White syndrome.
Topics: Adenosine; Adult; Atenolol; Electrocardiography; Female; Heart Rate, Fetal; Humans; Obstetric Labor | 1992 |